Top 45 alternative sites to evrysdi-hcp.com
-
evrysdi.com
-
curesma.org
-
signsofsma.com
-
spinalmuscularatrophy.net
-
smasupport.com
-
sinaisdeame.pt
-
tamiflu.com
-
aptiom.com
-
epidiolexhcp.com
-
veklury.com
-
evotazhcp.com
-
siklosusa.com
-
qbrexza.com
-
xyremhcp.com
-
apdermatology.com
-
xofluza-hcp.com
-
esbriethcp.com
-
enspryng-hcp.com
-
gavreto-hcp.com
-
pulmozyme.com
-
enspryng.com
-
ocrevus.com
-
esbriet.com
-
xofluza.com
-
erivedge.com
-
herceptin.com
-
rituxan-hcp.com
-
hemlibra.com
-
tecentriq.com
-
alecensa.com
-
rituxanhycela.com
-
tecentriq-hcp.com
-
rozlytrek.com
-
cellcept.com
-
strokeawareness.com
-
screenyourlungs.org
-
gavreto.com
-
gazyva-hcp.com
-
gazyva.com
-
genentech-forum.com
-
genentech-pro.com
-
rituxan.com
-
huntingtonsdisease.com
-
genentechoncology.com
-
genentechhemophilia.com
Evrysdi®️ (risdiplam) | Spinal Muscular Atrophy (SMA) Treatment
Evrysdi®️ (risdiplam) is approved to treat spinal muscular atrophy (SMA) in infants, children, & adults 2 months and older. See full safety for more information.
Home - Cure SMA
Cure SMA provides support to patients and families affected by spinal muscular atrophy and funds and directs research leading the way to a cure for SMA.
Author: Admin
Spinal muscular atrophy (SMA) symptoms - SMA Type 1, SMA Type 2
Spinal muscular atrophy develops in babies less than 6 months old (SMA Type 1) and can appear in babies between 7-18 months old (SMA Type 2). Learn how to spot them
Spinal Muscular Atrophy Health Info & Community
Learn about spinal muscular atrophy including symptoms, diagnosis, treatment, patient stories, & more from an SMA community perspective.
Author: Chaz Hayden
SMA Support Inc., Home of Spinal Muscular Atrophy
Dedicated to providing information, support and help for anyone facing the incurable genetic disease Spinal Muscular Atrophy (SMA). Learn about the disease, research, treatments, and life with the disease, speak with others in similar positions.
Sintomas atrofia muscular espinal (AME) - AME Tipo 1, AME Tipo 2
Spinal muscular atrophy develops in babies less than 6 months old (SMA Type 1) and can appear in babies between 7-18 months old (SMA Type 2). Learn how to spot them
Tamiflu® (oseltamivir phosphate) | Prescription Flu Treatment
Tamiflu® (oseltamivir phosphate) is an antiviral medicine for treatment of flu in people 2 weeks of age and older and for prevention of flu in people 1 year of age and older. See full safety for more information.
Partial-Onset Seizure Treatment | Aptiom® (eslicarbazepine acetate)
Discover APTIOM®, a partial-onset seizure (focal seizure) treatment option for patients 4 years of age and older. See safety and Prescribing Information.
FDA-Approved Rx Cannabidiol Official EPIDIOLEX® HCP Site
Discover the first and only FDA-approved prescription cannabidiol (CBD) for Dravet syndrome or LGS in patients 2 years of age and older. See Important Safety Information.
VEKLURY® (remdesivir) | Approved Treatment for COVID-19
Introducing VEKLURY® (remdesivir), an FDA approved, antiviral treatment for COVID-19. Official patient site. See Important Safety Information.
EVOTAZ® (atazanavir/cobicistat) **** Treatment | For Healthcare Providers
Learn about EVOTAZ® (atazanavir/cobicistat) for treatment-naïve patients with ****-1. See Full Prescribing Safety Information.
Hydroxyurea-based treatment for pediatric patients with sickle cell anemia – Siklos® (hydroxyurea)
Siklos® is the first and only FDA-approved prescription medicine that is used to reduce the frequency of painful crises and reduce the need for blood transfusion in children, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises. See Important Safety Information and Boxed Warning about myelosuppression and malignancies.
Author: Super User
QBREXZA® (glycopyrronium) Cloth | Excessive Underarm Sweating Option
QBREXZA is the first and only prescription cloth towelette approved to treat excessive underarm sweating (primary axillary hyperhidrosis) in people 9 years of age and older. See Important Safety Information, Full Prescribing Information, including Patient Product Information, and Instructions for Use on QBREXZA.com.
XYREM®—Treatment for Narcolepsy With Cataplexy and/or Excessive Daytime Sleepiness
Healthcare professionals can find information about XYREM® (sodium oxybate), a treatment for cataplexy and/or excessive daytime sleepiness (EDS) in narcolepsy for adults and pediatric patients ages 7 and older. See XYREM® prescribing information & BOXED Warning about serious side effects, CNS depression, misuse and abuse.
Adult & Pediatric Dermatology Chelsea MI | Dermatologist Ann Arbor | Acne, Botox & Skin Cancer
APD Adult & Pediatric Dermatology provides evidence-based skin care to patients of all ages in Ann Arbor & Chelsea Michigan. We offer a wide array of services including skin cancer screening as well as comprehensive medical treatments. Contact us at 734-385-7255 for more information.
Some websites with similar theme to evrysdi-hcp.com include:
Single-dose Flu Antiviral | XOFLUZA® (baloxavir marboxil) HCP
Find information for HCPs about XOFLUZA® (baloxavir marboxil), a single-dose **** antiviral treatment for influenza. See full safety for more information.
Esbriet® (pirfenidone) Information for Healthcare Professionals
Learn about Esbriet® (pirfenidone) as a possible treatment option for IPF, a progressive and irreversible fibrotic interstitial lung disease. See full safety for more information.
ENSPRYNG™ (satralizumab) | Efficacy, Safety, & Prescribing Information
ENSPRYNG™ (satralizumab) is an interleukin-6 (IL-6) receptor antagonist indicated as monotherapy or with immunosuppressive therapy for the treatment of NMOSD. See full safety for more information.
GAVRETO® (pralsetinib) for RET+ mNSCLC & Advanced Thyroid Cancer | HCP
Learn about GAVRETO (pralsetinib) for RET+ metastatic NSCLC or advanced thyroid cancer. See important safety for more information.
Other sites like evrysdi-hcp com
Cystic Fibrosis Treatment Option | Pulmozyme® (dornase alfa)
Pulmozyme® (dornase alfa) is a nebulized cystic fibrosis (CF) treatment option to help manage CF symptoms. See full safety for more information.
ENSPRYNG™ (satralizumab) | Neuromyelitis Optica Spectrum Disorder (NMOSD) Treatment
Learn about ENSPRYNG™ (satralizumab), a self-administered, monthly treatment for Neuromyelitis Optica Spectrum Disorder (NMOSD). See full safety for more information.
OCREVUS® (ocrelizumab) | Multiple Sclerosis (MS) Treatment
Learn about OCREVUS® (ocrelizumab), a prescription medicine used to treat adults with relapsing or primary progressive multiple sclerosis. See full safety for more information.
Idiopathic Pulmonary Fibrosis (IPF) Treatment | Esbriet® (pirfenidone)
Learn about Esbriet® (pirfenidone), a medication for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and irreversible fibrotic interstitial lung disease. See full safety for more information.
XOFLUZA® (baloxavir marboxil) | Prescription Flu Treatment
Learn about XOFLUZA® (baloxavir marboxil), a one-dose prescription flu treatment that attacks the flu virus at its source. See full safety for more information.
Erivedge® (vismodegib) | Advanced Basal Cell Carcinoma (aBCC) Treatment
Learn about Erivedge® (vismodegib) as a basal cell carcinoma treatment option for both metastatic and locally advanced carcinoma. See full safety, Boxed Warning, and Medication Guide for more information.
HER2+ Cancer Treatment Option | Herceptin® (trastuzumab)
Find information about Herceptin®, a treatment for Early and Metastatic **** Cancer and Stomach/GEJ Cancer. See full safety & Boxed Warnings for more information.
Treatment for RA, NHL, CLL, GPA, MPA and PV | RITUXAN® (rituximab)
HCP info about RITUXAN® (rituximab) treatment for RA, NHL, CLL, GPA, MPA and PV including indications, dosing, efficacy and support. Please see Important Safety Information including Boxed Warning and Full Prescribing Information for more information.
HEMLIBRA® (emicizumab-kxwh) | Hemophilia A Treatment
Learn about HEMLIBRA® (emicizumab-kxwh), a hemophilia A treatment approved for people with hemophilia A with or without factor VIII inhibitors. See full safety and BOXED WARNING.
Cancer Immunotherapy Treatment for NSCLC, ES-SCLC, HCC, Advanced Melanoma & mUC | TECENTRIQ® (atezolizumab)
Learn about TECENTRIQ® (atezolizumab), a cancer Immunotherapy treatment for Non-Small Cell Lung Cancer after surgery and chemo, Metastatic Non-Small Cell Lung Cancer (NSCLC), Extensive-Stage Small Cell Lung Cancer (ES-SCLC), Liver cancer (HCC), Advanced Melanoma & Advanced Bladder Cancer (mUC) | TECENTRIQ® (atezolizumab)
ALECENSA® (alectinib) and Information for Patients
Find information for patients about treatment with ALECENSA® (alectinib). See full safety for more information.
RITUXAN HYCELA for FL, DLBCL and CLL
Learn about RITUXAN HYCELA® for subcutaneous injection, a prescription antibody therapy used for FL, DLBCL and CLL. See important safety including Boxed Warnings for more information.
TECENTRIQ® (atezolizumab) HCP | Efficacy, Safety, PI & MOA
Information for healthcare professionals about the safety, efficacy, dosing, prescribing information and mechanism of action for TECENTRIQ® (atezolizumab). See full safety for additional information.
ROZLYTREK (entrectinib) ROS1 & TRK Inhibitor
Learn about ROZLYTREK (entrectinib), a treatment option for ROS1+ mNSCLC and certain NTRK fusion-positive solid tumors. See full safety for more information.
CellCept® (mycophenolate mofetil) | Transplant Rejection Medication
Learn about the CellCept® Co-pay Card and how CellCept (mycophenolate mofetil) is used for people who have had a kidney, heart, or liver transplant. See full safety for more information.
**** Information and Resources | **** Awareness
Learn about sudden signs of ****, **** risk factors, and why it is important to act immediately when reponding to a ****.
ScreenYourLungs.org | Lung Cancer Screening
Surviving lung cancer starts with a scan. Find out how you can get a lung cancer screening today.
RET+ mNSCLC & Advanced Thyroid Cancer Treatment | GAVRETO® (pralsetinib) Patient
Learn about GAVRETO for RET+ metastatic non-small cell lung cancer (mNSCLC) or advanced thyroid cancer. See important safety for more information.
GAZYVA® (obinutuzumab) Treatment, Indications, Dosing & Safety
GAZYVA® (obinutuzumab) Treatment, Indications, Dosing & Safety
Learn about GAZYVA® (obinutuzumab) for first-line, R/R follicular lymphoma & first-line CLL. See important safety including Boxed Warnings for more information.
What else evrysdi-hcp.com alternative websites
Genentech Forum | Managed Care Resources
Find helpful resources for managed care and health system decision-makers from Genentech, including oncology cost containment trends and care management workshops.
Genentech Pro
Find information on Genentech's breakthrough medicines led by innovative science. Genentech is a proud member of the Roche Group.
RITUXAN® (rituximab) Medication for RA, NHL, CLL, GPA, MPA & PV
Find info for patients about RITUXAN® (rituximab) medication for RA, NHL, CLL, GPA, MPA, and PV. See full safety and Boxed Warning for more information.
Huntington's Together | Sharing Wisdom from the Community
Learn about HD and find inspiration in the experiences, advice, and tips shared by the Huntington's disease community.
Cancer Information & Resources | Genentech Oncology
Find cancer information & resources. Explore new research in cancer & learn how Genentech is dedicated to investigating diverse biological pathways & disease targets.
Genentech in Hemophilia | We will continue to deliver on the needs of the hemophilia patient community
With your help, we will continue to deliver on the needs of the hemophilia patient community. That is our commitment to you.
